- active not recruitingPHASE3
A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough
This study is testing a new medicine, BLU-5937, for adults in the UK with a long-lasting cough that hasn't responded to other treatments. It aims to see if the medicine can reduce how often people cough over 24 weeks, compared to a dummy pill.
United States · Australia · Canada - recruitingPHASE4
Evaluation of Treatments for Dry or Productive Cough
This study looks at two throat sprays for coughs caused by common colds or other viruses. It checks how safe and tolerable they are for people between 18 and 65, and if they help with cough symptoms and daily life.
France - not yet recruitingPHASE4
A 2x2 Factorial, Randomized, Open-label Trial to Evaluate Neuromodulators and Cough Control Therapy in Patients With Refractory or Unexplained Chronic Cough
This study looks at new ways to help people with long-lasting coughs that haven't responded to usual treatments. It tests two medicines (low-dose morphine and pregabalin) and a special cough therapy, separately and together, to see which works best and is safest.
Canada - active not recruitingPHASE3
A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough
This study is testing a new medicine called BLU-5937 for adults with a stubborn, long-lasting cough that hasn't responded to other treatments. It aims to see if the medicine can reduce how often people cough, compared to a dummy pill.
United States · Argentina · Belgium - recruitingNA
A Non-pharmacological Cough Control Therapy
This study looks at a drug-free way to help people with certain lung diseases (Interstitial Lung Disease or ILD) who have a cough for more than 8 weeks. It wants to see if this new approach can reduce coughing and improve their daily lives.
Canada - recruiting
Development of a Cough Control Questionnaire (CCQ)
This study is developing a new questionnaire to better understand and measure how cough affects people's lives. It aims to help doctors and researchers accurately track changes in cough severity and how well treatments are working, similar to tools used for other lung conditions like asthma.
United Kingdom